Galapagos NV GLPG
Updated: 16 Jun 2026
No signal published yet
We already track Galapagos NV and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.
Email when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Temporary check — not Firelda's published signal.
General analysis — not personal advice.
Want to follow Galapagos NV? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Galapagos NV free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more
Recent News
In May 2024, Galapagos presented Phase 1 data for its CAR-T candidate GLPG5101 at the ASCO Annual Meeting, demonstrating a 100% objective response rate in non-Hodgkin lymphoma. The company is currently expanding its decentralized manufacturing network to support its clinical oncology programs.
What Firelda Watch includes for Galapagos NV
Add the company to your watchlist and get all of this automatically.
- Free: 3 companies on your watchlist
- Change history and monitoring for every company you follow
- Sunday weekly brief — a short weekly roundup
- Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
Want to follow Galapagos NV? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.
Follow Galapagos NV free Follow freeEmail when we publish a signal or something material happens · Sunday weekly brief
No card · No time limit on free tier · Upgrade when you need more